US Patent 10550099 Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Patent 10550099 was granted and assigned to FORMA Therapeutics on February, 2020 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10550099 Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
